Citations

Mayo Clinic

Showing 10 of 108572 citations.

Allergic Contact Dermatitis in Patients with Hidradenitis Suppurativa: A Retrospective Analysis
McKenzie, Ning C. , Schaefer, Lauren , Killian, Jill M. , Youssef, Molly J. , Davis, Mark D.P. , McKenzie, Ning, Killian, Jill, Youssef, Molly, Alavi, Afsáneh

Dermatitis® | January 3, 2024 | Volume: 35 | Issue: 5 | Pages: 525-527

10.1089/derm.2023.0124 | PMID 38170189 Get It

Optimal Delivery Choices for Pregnant Patients Living with HIV: A Comprehensive Decision-Making Guide
Nagarakanti, Sindhu , Nagarakanti, Sindhu, Vegunta, Suneela , Nagarakanti, Sandhya, Nagarakanti, Sandhya, Nagarakanti, Sindhu, Nagarakanti, Sandhya, Nagarakanti, Sandhya

Journal of Women's Health | January 3, 2024 | Volume: 33 | Issue: 4 | Pages: 551-552

10.1089/jwh.2023.0946 | PMID 38170181 Get It

Brain herniation and subsequent complications following partial resection of high‐grade glioma: A case report
Hanif, Sheheryar , Iqbal, Maham , Surani, Salim , Iqbal, Maham , Surani, Salim , Yousaf, Irfan , Kumari, Usha

Clinical Case Reports | January 3, 2024 | Volume: 12 | Issue: 1 | Pages: No page available

10.1002/ccr3.8407 | PMID 38173889 Get It

Key Clinical MessageThis case highlights the need for tailored strategies to address issues like brain herniation, subdural hygroma, and cerebrospinal fluid leak, which, if not managed promptly, can lead to long‐term neurological deficits. Additionally, the role of specialized facilities in delivering highly specialized care for managing such intricate cases cannot be understated.AbstractDecompressive craniectomy‐induced subdural hygroma (SDH) frequently coexists with external cerebral herniation, resulting in neurological impairments. The incidence of brain herniation through a craniectomy defect postoperatively is 25%. Brain herniation (BH), SDH, and cerebrospinal fluid leak require urgent neurosurgical management as they can lead to irreversible long‐term neurological deficits. We report a case of a 42‐year‐old male who presented with headache and grand mal seizures. He was diagnosed with herniation of brain parenchyma through the surgical defect with a displacement of the bone flap by a heterogeneously enhancing lesion in the left parietal lobe along with SDH in the left frontoparietal region post partial resection of high‐grade glioma. In this report, we discuss the pathogenesis and management strategies of brain herniation, wound infection, cerebrospinal fluid (CSF) leak, ipsilateral SDH, floating bone flap, and communicating hydrocephalus in an adult patient following partial resection of high‐grade glioma. This particular case emphasizes the value of an individualized patient‐centered surgical approach to minimize the risk of postoperative complications.
Response to letter to editor, re‐predictors of morbidity and in‐hospital mortality following procedure‐related cardiac tamponade
Deshpande, Saurabh , Swatari, Hiroyuki, Padmanabhan, Deepak , Chahal, Anwar A, Deshpande, Saurabh , Chahal, C. Anwar A.

Journal of Arrhythmia | January 3, 2024 | Volume: 40 | Issue: 1 | Pages: 200-201

10.1002/joa3.12983 | PMID 38333392 Get It

Review article: Pharmacologic management of obesity ‐ updates on approved medications, indications and risks
Lupianez‐Merly, Camille , Vosoughi, Kia , Camilleri, Michael , Dilmaghani, Saam , Camilleri, M

Alimentary Pharmacology & Therapeutics | January 3, 2024 | Volume: 59 | Issue: 4 | Pages: 475-491

10.1111/apt.17856 | PMID 38169126 Get It

SummaryBackgroundObesity has reached epidemic proportions, with >40% of the US population affected. Although traditionally managed by lifestyle modification, and less frequently by bariatric therapies, there are significant pharmacological advancements.AimsTo conduct a narrative review of the neurohormonal and physiological understanding of weight gain and obesity, and the development, clinical testing, indications, expected clinical outcomes, and associated risks of current FDA‐approved and upcoming anti‐obesity medications (AOMs).MethodsWe conducted a comprehensive review in PubMed for articles on pathophysiology and complications of obesity, including terms ‘neurohormonal’, ‘obesity’, ‘incretin’, and ‘weight loss’. Next, we searched for clinical trial data of all FDA‐approved AOMs, including both the generic and trade names of orlistat, phentermine/topiramate, bupropion/naltrexone, liraglutide, and semaglutide. Additional searches were conducted for tirzepatide and retatrutide ‐ medications expecting regulatory approval. Searches included combinations of terms related to mechanism of action, indications, side effects, risks, and future directions.ResultsWe reviewed the pathophysiology of obesity, including specific role of incretins and glucagon. Clinical data supporting the use of various FDA‐approved medications for weight loss are presented, including placebo‐controlled or, when available, head‐to‐head trials. Beneficial metabolic effects, including impact on liver disease, adverse effects and risks of medications are discussed, including altered gastrointestinal motility and risk for periprocedural aspiration.ConclusionAOMs have established efficacy and effectiveness for weight loss even beyond 52 weeks. Further pharmacological options, such as dual and triple incretins, are probable forthcoming additions to clinical practice for combating obesity and its metabolic consequences such as metabolic dysfunction‐associated steatotic liver disease.
ChatGPT as a resource for patient education in cosmetic dermatological procedures: A boon or a bane?
Rames, Melissa M. , Rames, Jess D. , Tooley, Andrea A. , Hausauer, Amelia K. , Munavalli, Girish S., Wyles, Saranya P. , O'Hern, Keegan , O’Hern, Keegan

Journal of Cosmetic Dermatology | January 3, 2024 | Volume: 23 | Issue: 3 | Pages: 1085-1086

10.1111/jocd.16166 | PMID 38168902 Get It

SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma
Martini, Andréa , Prasai, Kritika , Ahmed, Fowsiyo , Elnagar, Mamoun B., Giama, Nasra H., Guzzardo, Vincenza , Biasiolo, Alessandra, Fassan, Matteo , Yin, Jun , Pontisso, Patrizia , Roberts, Lewis R. , Zemla, Tyler J, Ahmed, Fowsiyo Y, Fassan, Matteo , Pontisso, Patrizia , Roberts, Lewis R , Zemla, Tyler , Elnagar, Mamoun

Cancers | January 3, 2024 | Volume: 16 | Issue: 1 | Pages: 225

10.3390/cancers16010225 | PMID 38201652 Get It

Cholangiocarcinoma (CCA), the second most common primary liver tumor, is associated with a dismal outcome, and useful prognostic markers are not currently available in clinical practice. SerpinB3, a serine protease inhibitor, was recently found to play a relevant role in malignant transformation in different cancers. The aim of the present study was to determine the expression of SerpinB3/4 in tissue and serum samples of patients with CCA in relation to clinical outcomes. SerpinB3/4 was assessed in the tissue microarrays (TMAs) of 123 surgically resected CCAs. ELISA assays were carried out in 188 patients with CCA to detect the free and IgM-linked forms of SerpinB3/4. Overall survival was analyzed in relation to SerpinB3/4 expression, and Cox models were used to identify the variables associated with survival. High levels of SerpinB3/4 (TMA score 2+/3+) were detected in 15 tumors (12.2%), characterized by a more advanced TNM stage (III/IV: 64.3% vs. 31.3%; p = 0.031) and lower overall patient survival, independently of CCA subclass (intrahepatic CCA: median 1.1 (0.8—Not Estimable, NE) vs. 2.4 (1.8–3.4) years; p = 0.0007; extrahepatic CCA: median 0.8 (0.2—NE) vs. 2.2 (1.5–5.4) years; p = 0.011). Vascular invasion (p = 0.027) and SerpinB3/4 scores (p = 0.0016) were independently associated with mortality in multivariate analysis. Patients who had detectable free or IgM-linked SerpinB3/4 in their serum showed poorer survival (1 vs. 2.4 years, p = 0.015, for free SerpinB3/4, and 1 vs. 2.6 years, p = 0.0026, for SerpinB3/4–IgM). In conclusion, high levels of SerpinB3/4 in tissue and serum in CCA are associated with poor outcomes after surgery, regardless of tumor subclass.
Values and preferences towards the use of prophylactic low-molecular-weight heparin during pregnancy: A convergent mixed-methods secondary analysis of data from the Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-T
Xie, Feng , Gravholt, Derek, Bates, Shannon M. , Hargraves, Ian , Pelayo, Irene , López, Sandra Redondo , Caño, Juan Antonio Millón, Alcántara, Milagros A Suito, Jack, Susan M. , Gravholt, Derek L.

No container title available | January 3, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-3807726/v1 Get It

Abstract Background: Venous thromboembolism (VTE) in pregnancy is a major cause of maternal morbidity and mortality, and the use of preventive low-molecular-weight heparin (LMWH) can be challenging. Clinical guidelines recommend eliciting pregnant individuals’ preferences towards the use of daily injections of LMWH and discussing the best option through a shared decision-making (SDM) approach. Our aim was to identify individuals’ preferences concerning each of the main clinical outcomes, and categorize attributes influencing the use of LMWH during pregnancy. Methods: Design: Convergent mixed-methods. Participants: Pregnant women or those planning a pregnancy with VTE recurrence risk. Intervention: A SDM intervention about thromboprophylaxis with LMWH in pregnancy. Analysis: Quantitatively, we report preference scores assigned to each of the health states. Qualitatively, we categorized preference attributes using Burke’s pentad of motives framework: scene, agent, agency, act, and purpose. We use mixed-method convergent analysis to report findings using side-by-side comparison of concordance/discordance. Results: The least valued health state was to experience a pulmonary embolism (PE), followed by major obstetrical bleeding (MOB), deep vein thrombosis (DVT), and using daily injections of LMWH (valued as closest to a ‘healthy pregnancy’). Women's previous experiences, access to care (scene) and shared decision-making (agent) affected preferences. LMWH's benefits were noted, but substantial drawbacks described (agency). The main goal was avoiding the risk of VTE (purpose). Side-by-side comparisons revealed concordance between motives and DVT and PE health states. Discordance appeared between using daily injections of LMWH and agent- and agency motives and between MOB and the agency motive. Conclusions: Mixed-methods provide a nuanced understanding of women's LMWH preferences, by quantifying health states preferences and exploring attributes qualitatively. Incorporating both methods may improve patient-centered care around preference-sensitive decisions in thromboprophylaxis during pregnancy.
Combined assessment of progressive apraxia of speech brain microstructure by diffusion tensor imaging tractography and multishell neurite orientation dispersion and density imaging
Gatto, Rodolfo G. , Meade, Gabriela , Clark, Heather M. , Utianski, Rene L. , Josephs, Keith A. , Whitwell, Jennifer L., Clark, Heather M , Utianski, Rene L , Whitwell, Jennifer L , Meade, Gabriela , Duffy, Joseph R. , Botha, Hugo , Machulda, Mary M. , Whitwell, Jennifer

Brain and Behavior | January 2, 2024 | Volume: 14 | Issue: 1 | Pages: No page available

10.1002/brb3.3346 | PMID 38376044 Get It

Abstract Background Progressive apraxia of speech (PAOS) is characterized by difficulties with motor speech programming and planning. PAOS targets gray matter (GM) and white matter (WM) microstructure that can be assessed using diffusion tensor imaging (DTI) and multishell applications, such as neurite orientation dispersion and density imaging (NODDI). In this study, we aimed to apply DTI and NODDI to add further insight into PAOS tissue microstructure. Methods Twenty‐two PAOS patients and 26 age‐ and sex‐matched controls, recruited by the Neurodegenerative Research Group (NRG) at Mayo Clinic, underwent diffusion MRI on 3T MRI. Brain maps of fractional anisotropy (FA) and mean diffusivity (MD) from DTI and intracellular volume fraction (ICVF) and isotropic volume fraction (IsoVF) from NODDI were generated. Global WM and GM, and specific WM tracts were identified using tractography and lobar GM regions. Results Global WM differences between PAOS and controls were greatest for ICVF, and global GM differences were greatest for MD and IsoVF. Abnormalities in key WM tracts involved in PAOS, including the body of the corpus callosum and frontal aslant tract, were identified with FA, MD, and ICVF, with excellent differentiation of PAOS from controls (area under the receiver operating characteristic curves >.90). MD and ICVF identified abnormalities in arcuate fasciculus, thalamic radiations, and corticostriatal tracts. Significant correlations were identified between an index of articulatory errors and DTI and NODDI metrics from the arcuate fasciculus, frontal aslant tract, and inferior longitudinal fasciculus. Conclusions DTI and NODDI represent different aspects of brain tissue microstructure, increasing the number of potential biomarkers for PAOS.
Hyperglycemia Suppresses Lactate Clearance During Exercise in Type 1 Diabetes
ROMERES, DAVIDE, RUCHI, FNU, Carter, Rickey E. , Cobelli, Claudio , Basu, Rita , Basu, Ananda , Carter, Rickey E , Cobelli, Claudio , Basu, Ananda , Yadav, Yogesh

The Journal of Clinical Endocrinology & Metabolism | January 2, 2024 | Volume: 109 | Issue: 9 | Pages: e1720-e1731

10.1210/clinem/dgae005 | PMID 38174728 Get It

Abstract Context Circulating lactate concentration is an important determinant of exercise tolerance. Objective This work aimed to determine the role of hyperglycemia on lactate metabolism during exercise in individuals with type 1 diabetes (T1D). Methods The protocol at the University of Virginia compared 7 T1D participants and 7 participants without diabetes (ND) at euglycemia (5.5 mM) or hyperglycemia (9.2 mM) in random order in T1D and at euglycemia in ND. Intervention included [1-13C] lactate infusion, exercise at 65% maximal oxygen uptake (VO2max), euglycemia, and hyperglycemia visits. The main outcome measure was lactate turnover before, during, and after 60 minutes of exercise at 65% VO2max. Results A 2-compartment model with loss only from the peripheral compartment described lactate kinetics. Volume of distribution of the accessible compartment was similar between T1D and ND individuals (P = .76) and concordant with plasma volume (∼40 mL/kg). Circulating lactate concentrations were higher (P < .001) in T1D participants during exercise at hyperglycemia than euglycemia. Exercise-induced lactate appearance did not differ (P = .13) between hyperglycemia and euglycemia. However, lactate clearance (CL) was lower (P = .03) during hyperglycemia than euglycemia in T1D participants. There were no differences in any of the aforementioned parameters between T1D and ND participants during euglycemia. Conclusion Hyperglycemia modulates lactate metabolism during exercise by lowering CL, leading to higher circulating lactate concentrations in T1D individuals. This novel observation implies that exercise during hyperglycemia can lead to higher circulating lactate concentrations thus increasing the likelihood of reaching the lactate threshold sooner in T1D, and has high translational relevance both for providers and recreationally active people with T1D.